BIOGEN INC. Settlement Liabilities, Current
BIOGEN INC. (BIIB) had Settlement Liabilities, Current of $82.30 million as of 2024-09-30, per its 10-Q filed 2024-10-30.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:SettlementLiabilitiesCurrent · last filed 2024-10-30
- 2024-09-30: Settlement Liabilities, Current $82.30M.
- 2024-06-30: Settlement Liabilities, Current $77.40M.
- 2024-03-31: Settlement Liabilities, Current $79.20M.
- 2023-12-31: Settlement Liabilities, Current $117.50M.
| Period end | Settlement Liabilities, Current |
|---|---|
| 2024-09-30 | $82.30M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $77.40M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $79.20M 10-Q · filed 2024-04-24 |
| 2023-12-31 | $117.50M 10-Q · filed 2024-10-30 |
| 2023-09-30 | $1.41B 10-Q · filed 2023-11-08 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-14 |
| 2022-09-30 | $900.00M 10-Q · filed 2022-10-25 |
| 2022-06-30 | $900.00M 10-Q · filed 2022-07-20 |
| 2021-12-31 | $0.00 10-Q · filed 2022-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |